Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
期刊:Jpad-Journal of Prevention of Alzheimers Disease
影响因子:7.800
doi:10.1016/j.tjpad.2024.100016
Macfarlane Stephen, Grimmer Timo, Teo Ken, O'Brien Terence J, Woodward Michael, Grunfeld Jennifer, Mander Alastair, Brodtmann Amy, Brew Bruce J, Morris Philip, Short Cathy, Kurrle Susan, Lai Rosalyn, Bharadwaj Sneha, Drysdale Peter, Sturm Jonathan, Lewis Simon J G, Barton David, Kalafatis Chris, Sharif Saif, Perry Richard, Mannering Nicholas, MacSweeney J Emer, Pearson Stephen, Evans Craig, Krishna Vivek, Thompson Alex, Munisamy Malathy, Bhatt Neel, Asher Aliya, Connell Sandra, Lynch Jennifer, Rutgers Sterre Malou, Dautzenberg Paul Lj, Prins Niels, Oschmann Patrick, Frölich Lutz, Tacik Pawel, Peters Oliver, Wiltfang Jens, Henri-Bhargava Alexandre, Smith Eric, Pasternak Stephen, Frank Andrew, Chertkow Howard, Ingram Jennifer, Hsiung Ging-Yuek Robin, Brittain Rodney, Tartaglia Carmela, Cohen Sharon, Villa Luca M, Gordon Elizabeth, Jubault Thomas, Guizard Nicolas, Tucker Amanda, Kaufmann Walter E, Jin Kun, Chezem William R, Missling Christopher U, Sabbagh Marwan N